Skip to main content

Advertisement

SpringerLink
Log in

Cardiac Imaging in Latin America: Chagas Heart Disease

  • Specific Populations and Emerging Markets (V Dilsizian and T Schindler, Section Editor)
  • Published:
Current Cardiovascular Imaging Reports Aims and scope Submit manuscript

Abstract

Patients with Chagas heart disease can be evaluated for diagnostic and prognostic purposes using several imaging methods, including the plain chest radiography and various echocardiography techniques for biventricular systolic and diastolic function assessment, myocardial perfusion scintigraphy for uncovering microvascular disturbances, and 123iodine-MIBG labeling of sympathetic myocardial innervation, MRI for detection and quantitation of myocardial fibrosis, and coronary angiography during cardiac catheterization to characterize the mechanism of myocardial ischemia. Through the careful analysis and integration of findings provided by the application of these imaging methods to patients with various stages of chronic Chagas cardiomyopathy, it has been possible to improve considerably the understanding of some pathophysiological peculiarities of the disease. These include: (a) the predominant systemic congestion when cardiac failure supervenes, due to early impairment of RV function; (b) the early typical LV regional wall motion abnormalities, topographically correlated with microvascular ischemic defects despite normal coronary arteries, and preceded by local sympathetic denervation; (c) the characteristic extensive myocardial fibrosis that is a hallmark of the disease and is causally related to the frequent occurrence of sudden death even in patients with globally preserved LV systolic function. Ongoing research, mainly focused on the refinement of echocardiographic techniques and further exploration of nuclear and MRI methods, have the potential to contribute to a better prognostic stratification of patients with chronic Chagas cardiomyopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13
Fig. 14

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Marin-Neto JA, Almeida Filho OC, Pazin-Filho A, Maciel BC. [Indeterminate form of Chagas’ disease. Proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy]. Arquivos brasileiros de cardiologia. 2002 Dec;79(6):623–7. PubMed PMID: 12532246. Forma indeterminada da molestia de chagas: proposta de novos criterios de caracterizacao e perspectivas de tratamento Precoce da cardiomiopatia.

  2. Rassi Jr A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388–402. This paper provides the most comprehensive and uptdated review of all relevant features of Chagas disease, especially those pertinent to chronic Chagas cardiomyopathy that form a basis for the understanding of how imaging methods can be useful in this context.

    Article  PubMed  Google Scholar 

  3. Acquatella H, Schiller N. Echocardiographic recognition of Chagas’ disease and endomyocardial fibrosis. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 1988;1(1):60–8.

    Article  CAS  Google Scholar 

  4. Patel AR, Lima C, Parro A, Arsenault M, Vannan MA, Pandian NG. Echocardiographic analysis of regional and global left ventricular shape in Chagas’ cardiomyopathy. Am J Cardiol. 1998;82(2):197–202.

    Article  CAS  PubMed  Google Scholar 

  5. Borges-Pereira J, Xavier SS, de Sousa AS, de Castro JA, Zauza PL, Coura JR. Prevalence of left ventricular aneurysms among chronic Chagas disease patients from two areas in the state of Piaui, Brazil]. Rev Soc Bras Med Trop. 2007;40(5):521–6. Prevalencia de aneurismas do ventriculo esquerdo em pacientes chagasicos cronicos de duas areas do Estado do Piaui.

    Article  PubMed  Google Scholar 

  6. Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, et al. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart. 2004;90(6):655–60.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Rassi Jr A, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115(9):1101–8.

    Article  PubMed  Google Scholar 

  8. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke J Cereb Circ. 2005;36(5):965–70.

    Article  Google Scholar 

  9. Carod-Artal FJ, Vargas AP, Melo M, Horan TA. American trypanosomiasis (Chagas’ disease): an unrecognised cause of stroke. J Neurol Neurosurg Psychiatry. 2003;74(4):516–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Pellett AA, Tolar WG, Merwin DG, Kerut EK. The Tei index: methodology and disease state values. Echocardiogr. 2004;21(7):669–72.

    Article  Google Scholar 

  11. Pazin-Filho A, Romano MM, Gomes Furtado R, de Almeida Filho OC, Schmidt A, Marin-Neto JA, et al. Left ventricular global performance and diastolic function in indeterminate and cardiac forms of Chagas’ disease. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 2007;20(12):1338–43.

    Article  Google Scholar 

  12. Pazin-Filho A, Romano MM, Almeida-Filho OC, Furuta MS, Viviani LF, Schmidt A, et al. Minor segmental wall motion abnormalities detected in patients with Chagas’ disease have adverse prognostic implications. Braz J Med Biol Res Rev Bras Pesquisas Med Biol Soc Bras Biofisica. 2006;39(4):483–7.

    CAS  Google Scholar 

  13. Garcia-Alvarez A, Sitges M, Regueiro A, Poyatos S, Jesus Pinazo M, Posada E, et al. Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J Card Fail. 2011;17(12):1028–34.

    Article  PubMed  Google Scholar 

  14. Barbosa MM, Costa Rocha MO, Vidigal DF, Bicalho Carneiro Rde C, Araujo RD, Palma MC, et al. Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas’ disease. Echocardiogr. 2014;31(5):623–30.

    Article  Google Scholar 

  15. Sousa AC, Marin-Neto JA, Maciel BC, Gallo Junior L, Amorim Dde S, Barreto-Martins LE. Systolic and diastolic dysfunction in the indeterminate, digestive and chronic cardiac forms of Chagas’ disease. Arq Bras Cardiol. 1988;50(5):293–9. Disfuncao sistolica e diastolica nas formas indeterminada, digestiva e cardiaca cronica da molestia de Chagas.

    CAS  PubMed  Google Scholar 

  16. Barbosa MM, Nunes Mdo C, Ribeiro AL, Barral MM, Rocha MO. N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle. Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. 2007;8(3):204–12.

    Article  Google Scholar 

  17. Oliveira BM, Botoni FA, Ribeiro AL, Pinto AS, Reis AM, Nunes Mdo C, et al. Correlation between BNP levels and Doppler echocardiographic parameters of left ventricle filling pressure in patients with Chagasic cardiomyopathy. Echocardiograph. 2009;26(5):521–7.

    Article  Google Scholar 

  18. Barros MV, da Costa Rocha MO, Ribeiro AL, Machado FS. Tissue Doppler imaging enables the identification of diastolic dysfunction of pseudonormal pattern in Chagas’ disease. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 2001;14(5):353–9.

    Article  CAS  Google Scholar 

  19. Barros MV, Machado FS, Ribeiro AL, Rocha MO. Diastolic function in Chagas’ disease: an echo and tissue Doppler imaging study. Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. 2004;5(3):182–8.

    Article  CAS  Google Scholar 

  20. Garcia-Alvarez A, Sitges M, Pinazo MJ, Regueiro-Cueva A, Posada E, Poyatos S, et al. Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS neglected tropical diseases. 2010;4(9). PubMed PMID: 20877635. Pubmed Central PMCID: 2943653.

  21. Nascimento CA, Gomes VA, Silva SK, Santos CR, Chambela MC, Madeira FS, et al. Left atrial and left ventricular diastolic function in chronic Chagas disease. Journal of the American Society of Echocardiography official publication of the American Society of Echocardiography. 2013 Sep 18. PubMed PMID: 24055123. A more recent paper that, using more elaborated techniqual approaches, confirms findings of previous work showing early impairment of ventricular performance in patients with Chagas disease.

  22. Marques DS, Canesin MF, Barutta Junior F, Fuganti CJ, Barretto AC. Evaluation of asymptomatic patients with chronic Chagas disease through ambulatory electrocardiogram, echocardiogram and B-Type natriuretic peptide analyses. Arq Bras Cardiol. 2006;87(3):336–43.

    Article  PubMed  Google Scholar 

  23. Nunes MP, Colosimo EA, Reis RC, Barbosa MM, da Silva JL, Barbosa F, et al. Different prognostic impact of the tissue Doppler-derived E/e’ ratio on mortality in Chagas cardiomyopathy patients with heart failure. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2012;31(6):634–41.

    Article  Google Scholar 

  24. Rassi Jr A, Rassi A, Correia LC. Should tissue Doppler echocardiography be used to improve prediction of mortality risk in patients with Chagas cardiomyopathy? Int J Cardiol. 2011;149(1):134–5.

    Article  PubMed  Google Scholar 

  25. Mancuso FJ, Almeida DR, Moises VA, Oliveira WA, Mello ES, Poyares D, et al. Left atrial dysfunction in chagas cardiomyopathy is more severe than in idiopathic dilated cardiomyopathy: a study with real-time three-dimensional echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 2011;24(5):526–32.

    Article  Google Scholar 

  26. Acquatella H, Perez JE, Condado JA, Sanchez I. Limited myocardial contractile reserve and chronotropic incompetence in patients with chronic Chagas’ disease: assessment by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;33(2):522–9.

    Article  CAS  PubMed  Google Scholar 

  27. Marin-Neto JA, Marzullo P, Sousa AC, Marcassa C, Maciel BC, Iazigi N, et al. Radionuclide angiographic evidence for early predominant right ventricular involvement in patients with Chagas’ disease. Can J Cardiol. 1988;4(5):231–6.

    CAS  PubMed  Google Scholar 

  28. Marin Neto JA, Simoes MV, Sarabanda AV. Chagas’ heart disease. Arq Bras Cardiol. 1999;72(3):247–80.

    Article  CAS  PubMed  Google Scholar 

  29. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109–23. Epub 2007/03/07. eng.

    Article  PubMed  Google Scholar 

  30. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the european society of cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 2010;23(7):685–713.

    Article  Google Scholar 

  31. Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, et al. Multimodality comparison of quantitative volumetric analysis of the right ventricle. J Am Coll Cardiol Img. 2010;3(1):10–8.

    Article  Google Scholar 

  32. Shiran H, Zamanian RT, McConnell MV, Liang DH, Dash R, Heidary S, et al. Relationship between echocardiographic and magnetic resonance derived measures of right ventricular size and function in patients with pulmonary hypertension. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2014;27(4):405–12. A seminal article aiming at standardization and correlation of echocardiographic and cardiac resonance imaging methods for the analysis of right ventricular function, in the context of the overload imposed by pulmonary hypertension.

    Article  Google Scholar 

  33. Sato T, Tsujino I, Ohira H, Oyama-Manabe N, Yamada A, Ito YM, et al. Validation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertension. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 2012;25(3):280–6.

    Article  Google Scholar 

  34. Barros MV, Machado FS, Ribeiro AL, Da Costa Rocha MO. Detection of early right ventricular dysfunction in Chagas’ disease using Doppler tissue imaging. J Am Soc Echocardiogr Off Publ Am Soc Echocardiog. 2002;15(10 Pt 2):1197–201.

    Article  Google Scholar 

  35. Nunes Mdo C, Barbosa Mde M, Brum VA, Rocha MO. Morphofunctional characteristics of the right ventricle in Chagas’ dilated cardiomyopathy. Int J Cardiol. 2004;94(1):79–85.

    Article  PubMed  Google Scholar 

  36. Feit A, El-Sherif N, Korostoff S. Chagas’ disease masquerading as coronary artery disease. Arch Intern Med. 1983;143(1):144–5.

    Article  CAS  PubMed  Google Scholar 

  37. Marin-Neto JA, Rassi Jr A, Simoes MV, Maciel BC, Schmidt A. Chagas Heart disease. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, editors. Evidence-Based Cardiology2010. p. 18.

  38. Hammermeister KE, Caeiro T, Crespo E, Palmero H, Gibson DG. Left ventricular wall motion in patients with Chagas’s disease. Br Heart J. 1984;51(1):70–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Hagar JM, Rahimtoola SH. Chagas’ heart disease in the United States. N Engl J Med. 1991;325(11):763–8.

    Article  CAS  PubMed  Google Scholar 

  40. Simoes MV, Ayres EM, Santos JL, Schmidt A, Pintya AO, Maciel BC, et al. Detection of myocardial ischemia in chronic Chagas disease patients with atypic precordial pain by exercise and Holter tests. Arq Bras Cardiol. 1993;60(5):315–9. Deteccao de isquemia miocardica em chagasicos cronicos com precordialgia atipica pelos testes de esforco e Holter.

    CAS  PubMed  Google Scholar 

  41. Kuschnir E, Kustich F, Epelman M, Santamarina N, Podio RB. Valoration de fluxo miocardico con Rb 86 en pacientes con cardiopatia chagasica con insuficiencia coronaria y en controles normales. Parte 1: estudios basales. Arq Bras Cardiol. 1974;27:9.

    Google Scholar 

  42. Kuschnir E, Kustich F, Epelman M, Santamarina N, Podio RB. Valoration de fluxo miocardico con Rb 86 en pacientes con cardiopatia chagasica con insuficiencia coronaria y en controles normales. Parte 2: respuesta al ejercicio y a la cardiotonificacion aguda. Arq Bras Cardiol. 1974;27:11.

    Google Scholar 

  43. Marin-Neto JA, Marzullo P, Marcassa C, Gallo Junior L, Maciel BC, Bellina CR, et al. Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol. 1992;69(8):780–4.

    Article  CAS  PubMed  Google Scholar 

  44. Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol. 2000;86(9):975–81.

    Article  CAS  PubMed  Google Scholar 

  45. Peix A, Garcia R, Sanchez J, Cabrera LO, Padron K, Vedia O, et al. Myocardial perfusion imaging and cardiac involvement in the indeterminate phase of Chagas disease. Arq Bras Cardiol. 2013;100(2):114–7. Another independent research group describing myocardial perfusion disturbances in patients with the indeterminate form of chornic Chagas disease, corroborating the notion that these early derangements may be important pathogenic factors for the development of Chagas cardiomyopathy.

    Article  PubMed  Google Scholar 

  46. Marin-Neto JA, Simoes MV, Rassi Junior A. Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements. Rev Soc Bras Med Trop. 2013;46(5):536–41. This paper is an extensive review of the coronary microvascular disturbances that contribute to the complex pathogenesis of Chagas heart disease.

    Article  PubMed  Google Scholar 

  47. Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. J Am Coll Cardiol Img. 2009;2(2):164–72.

    Article  Google Scholar 

  48. Arreaza N, Puigbo JJ, Acquatella H, Casal H, Giordano H, Valecillos R, et al. Radionuclide evaluation of left-ventricular function in chronic Chagas’ cardiomyopathy. J Nucl Med Off Publ Soc Nucl Med. 1983;24(7):563–7.

    CAS  Google Scholar 

  49. Marin-Neto JA, Bromberg-Marin G, Pazin-Filho A, Simoes MV, Maciel BC. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas’ disease. Int J Cardiol. 1998;65(3):261–9.

    Article  CAS  PubMed  Google Scholar 

  50. Simoes MV, Oliveira LF, Hiss FC, Figueiredo AB, Pintya AO, Maciel BC, et al. Characterization of the apical aneurysm of chronic Chagas’ heart disease by scintigraphic image co-registration. Arq Bras Cardiol. 2007;89(2):119–21.

    Article  PubMed  Google Scholar 

  51. Oliveira JSM, Oliveira JAM, Frederigue Junior U, Lima-Filho EC. Apical aneurysm in Chagas, heart disease. Br Heart J. 1981;46:5.

    Article  Google Scholar 

  52. Mott KE, Hagstrom JW. The pathologic lesions of the cardiac autonomic nervous system in chronic Chagas’ myocarditis. Circulation. 1965;31:273–86.

    Article  CAS  PubMed  Google Scholar 

  53. Köberle F. Pathogenesis of Chagas’ disease. CIBA Found Symp. 1974;20:21.

    Google Scholar 

  54. Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simoes MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med Off Publ Soc Nucl Med. 2011;52(4):504–10. This study demonstrates the frequent concomitance of myocardial perfusion disturbance and regional myocardial sympathetic denervation in patients running through the early evolutive stages of chronic Chagas heart disease. In addition, this is the first study to indicate a relevant role for myocardial sympathetic denervation as a potential triggering mechanism of malignant ventricular arrhythmia in this myocardial disease.

    CAS  Google Scholar 

  55. Landesmann MC, da Fonseca LM, de Pereira B, do Nascimento EM, Rosado-de-Castro PH, de Souza SA, et al. Iodine-123 metaiodobenzylguanidine cardiac imaging as a method to detect early sympathetic neuronal dysfunction in chagasic patients with normal or borderline electrocardiogram and preserved ventricular function. Clin Nucl Med. 2011;36(9):757–61.

    Article  PubMed  Google Scholar 

  56. Macedo R, Schmidt A, Rochitte CE, Lima JA, Bluemke DA. MRI to assess arrhythmia and cardiomyopathies. J Magn Reson Imaging JMRI. 2006;24(6):1197–206.

    Article  Google Scholar 

  57. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115(15):2006–14.

    Article  PubMed Central  PubMed  Google Scholar 

  58. de Souza AP, Tang B, Tanowitz HB, Araujo-Jorge TC, Jelicks EL. Magnetic resonance imaging in experimental Chagas disease: a brief review of the utility of the method for monitoring right ventricular chamber dilatation. Parasitol Res. 2005;97(2):87–90.

    Article  PubMed  Google Scholar 

  59. Durand JL, Tang B, Gutstein DE, Petkova S, Teixeira MM, Tanowitz HB, et al. Dyskinesis in Chagasic myocardium: centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. Magn Reson Imaging. 2006;24(8):1051–7.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Ueno Y, Nakamura Y, Takahashi M, Inoue T, Endo S, Kinoshita M, et al. A highly suspected case of chronic Chagas’ heart disease diagnosed in Japan. Jpn Circ J. 1995;59(4):219–23.

    Article  CAS  PubMed  Google Scholar 

  61. Sooklim K, Maskiell C, Brett NJ, Hansen M, Slaughter RE, Hamilton-Craig CR. Chagas cardiomyopathy with left ventricular apical aneurysm: first case report in Australia. Intern Med J. 2011;41(12):846–8.

    Article  CAS  PubMed  Google Scholar 

  62. Kalil R, Bocchi EA, Ferreira BM, de Lourdes Higuchi M, Lopes NH, Magalhaes AC, et al. Magnetic resonance imaging in chronic Chagas cardiopathy. Correlation with endomyocardial biopsy findings. Arq Bras Cardiol. 1995;65(5):413–6. Imagem por ressonancia magnetica na cardiopatia chagasica cronica. Correlacao com biopsia endomiocardica. por.

    CAS  PubMed  Google Scholar 

  63. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol. 2005;46(8):1553–8.

    Article  PubMed  Google Scholar 

  64. Regueiro A, Garcia-Alvarez A, Sitges M, Ortiz-Perez JT, De Caralt MT, Pinazo MJ, et al. Myocardial involvement in Chagas disease: insights from cardiac magnetic resonance. Int J Cardiol. 2013;165(1):107–12.

    Article  PubMed  Google Scholar 

  65. Baroldi G, Oliveira SJ, Silver MD. Sudden and unexpected death in clinically ‘silent’ Chagas’ disease. A Hypothesis Int J Cardiol. 1997;58(3):263–8.

    Article  CAS  Google Scholar 

  66. Volpe GJ, Trad HS, Koenigkam-Santos M, Moreira HT, Maciel BC, M-N JA, et al. Evaluation of Chagas heart disease by cardiac magnetic resonance after an aborted sudden cardiac event. J Cardiovasc Magn Reson. 2012;14(1):176. First report showing that late gadolinium enhancement was present in cases presenting sudden cardiac death as first manifestation of Chagas heart disease.

    Article  Google Scholar 

  67. Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, et al. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arq Bras Cardiol. 2012;98(5):421–30.

    Article  PubMed  Google Scholar 

  68. Tassi EM, Continentino MA, Nascimento EM, Pereira Bde B, Pedrosa RC. Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction. Arq Bras Cardiol. 2014;102(5):456–64. This paper highlights the striking feature Chagas cardiomyopathy, with patients who develop malignant arrhythmia in the absence of global ventricular systolic dysfunction, but showing focal areas of myocardial fibrosis.

  69. Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol. 2008;51(25):2414–21.

    Article  PubMed Central  PubMed  Google Scholar 

  70. Sechtem U, Mahrholdt H, Vogelsberg H. Cardiac magnetic resonance in myocardial disease. Heart. 2007;93(12):1520–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Schmidt A, Romano MMD, Maciel BC, Marin-Neto JA. Cardiac magnetic resonance imaging for sudden cardiac death. Much more than another method to measure LVEF. Curr Cardioavasc Imaging Rep. 2013;6:431–4.

    Article  Google Scholar 

  72. Rassi Jr A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al. Development and validation of a risk score for predicting death in Chagas heart disease. N Engl J Med. 2006;355:799.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Figures 4, 5, 6, and 8 were courtesy from Dr. Henrique Turin Moreira.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

J. Antônio Marin-Neto, Minna M. Dias Romano, Benedito Carlos Maciel, Marcus Vinícius Simões, and André Schmidt declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Interventional Cardiology Unit, Division of Cardiology, Medical School of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil

    J. Antônio Marin-Neto, Minna M. Dias Romano, Benedito Carlos Maciel, Marcus Vinícius Simões & André Schmidt

Authors
  1. J. Antônio Marin-Neto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Minna M. Dias Romano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Benedito Carlos Maciel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcus Vinícius Simões
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. André Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Antônio Marin-Neto.

Additional information

This article is part of the Topical Collection on Specific Populations and Emerging Markets

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marin-Neto, J.A., Romano, M.M.D., Maciel, B.C. et al. Cardiac Imaging in Latin America: Chagas Heart Disease. Curr Cardiovasc Imaging Rep 8, 9 (2015). https://doi.org/10.1007/s12410-015-9324-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12410-015-9324-2

Keywords

Search

Navigation